Incidence and prevalence of multiple sclerosis in Europe: a systematic review
about
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literatureMultiple Sclerosis in Pediatrics: Current Concepts and Treatment OptionsOptical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseThe hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.Regulatory T cells in multiple sclerosis and myasthenia gravis.Environmental factors and multiple sclerosis severity: a descriptive study.Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic reviewMultiple sclerosis in US minority populations: Clinical practice insights.Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.Effect of interferon-β1α therapy on multiple sclerosis based on gadolinium-enhancing or active T2 magnetic resonance imaging outcomes: a meta-analysis.Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western SardiniaCost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala studyHigh incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).Sexual function in multiple sclerosis and associations with demographic, disease and lifestyle characteristics: an international cross-sectional study.Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System.Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems.Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulationSelf-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS RegistryClinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results.Stress Urinary Incontinence in Women With Multiple Sclerosis.Longitudinal study of alexithymia and multiple sclerosis.The current role of mitoxantrone in the treatment of multiple sclerosis.Vitamin D and multiple sclerosis—from epidemiology to prevention.Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis.Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.Environmental control of autoimmune inflammation in the central nervous system.Cancer immunotherapy in patients with preexisting autoimmune disorders.Disability and progression in Afro-descendant patients with multiple sclerosis.Multiple Sclerosis Epidemiology in Europe.A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK.The influence of sodium on pathophysiology of multiple sclerosis.Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.Multiple Sclerosis in Latin Americans: Genetic Aspects.Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
P2860
Q27015089-C033EC09-0472-4848-9247-22D81FB46BBBQ28067298-430FBEC9-8432-48FA-8735-73020138E024Q28076588-F83796BF-7290-4CA5-A707-BCF96BB97AABQ28081150-CD56C26E-2276-4427-8359-B9CCAB453D37Q30235362-A6BB11EF-A5FA-4659-9E98-84C2ECDD34F9Q33784969-3BBC078A-3F9B-4010-8FEA-3441C24F065AQ33834066-ED43E4A6-923C-4B27-8583-8838954D1F40Q33840891-A0421147-9090-4495-A253-994ECE4450FDQ35087429-43E8ADA7-0FC0-413A-AE4F-0B4A04E8A102Q35500198-C96C646B-C366-46F6-8143-0E57DE11D4BDQ35621002-C7646F45-C2BD-4D4D-BB27-F2E5EE5216E2Q35721504-1EE0EB2D-D6FE-46F7-BD3B-A878F2E2F43EQ35842934-524934AD-10DD-4EFA-BF42-90AF46387A49Q35921568-6D5C53F6-25D1-44B4-9139-57609777AA3CQ36110871-43CC3148-82C7-4369-81AC-BFB2F80AEA88Q36145079-EA01623E-A3D5-4B03-98AA-C548793CE88DQ36171531-C497DEA1-1B5B-4CCC-8D25-1C8093AB8753Q36171725-86A80B3F-AB37-4129-BF2B-CB47AAC1B251Q36183167-E97B2209-92C4-4F97-B5EF-DB18AB1E087CQ36492533-A54F41A0-5BE1-4619-A72F-4E31593ECE98Q36783878-D7CADB15-4171-4C45-A87B-377CDACB8038Q36957280-91C82A1A-90F9-4EFE-B138-ED5F426B9D75Q37226497-55FC5B2F-CE17-4F66-A50E-0DC047A5A300Q37330113-F74309AE-CE07-449A-9598-343C384531C2Q37373356-450B41F6-489E-49C1-B60B-3E111267607BQ37608614-8141AF0B-BEDF-42CF-86E4-7AE0B7C8471FQ38212259-66DA6C2C-B34C-42D3-BC8D-5F728D938B2CQ38517185-A22DA3DA-E852-4EAA-ADA4-AEC97AA36FD1Q38570681-CF5CABBC-72AE-4BA9-B502-C0B3FC6B622EQ38661416-13B1343C-C37E-47E1-A7EF-CC722F31A3E9Q38689502-C53E8B1D-9ED4-4373-A422-34E314B8D350Q38973515-0DFD8156-D5EC-46D3-A46A-F5E05271F07DQ38978399-1B05A3A6-1D8A-492D-8CA8-88250BF3F740Q38985395-A5B3B479-4F1F-4EEF-9EF8-DD0D75F1037DQ39017560-3F094646-DEF6-4754-85F8-387D9A32C3FDQ39069412-D9C34456-E6DC-40FE-B88D-E2A5745965EAQ39081430-FB8B778D-378E-4AB1-9EAE-49F9D30BAD4CQ39342178-1C359F87-2BB4-4B7A-B983-FD7AF7325165Q39390164-25752389-66AE-4C69-8816-EC7D14C8D33AQ39620091-69D16AB9-C7D7-4C54-9B30-0C5BCB551597
P2860
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@ast
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@en
type
label
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@ast
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@en
prefLabel
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@ast
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@en
P2093
P2860
P50
P356
P1433
P1476
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
@en
P2093
Charity Evans
Christina Wolfson
James J Marriott
John D Fisk
Jonathan Dykeman
Naila Makhani
Nathalie Jetté
Sarah A Morrow
Sarah Gabrielle Béland
Sophie Kulaga
P2860
P2888
P356
10.1186/1471-2377-13-128
P5008
P577
2013-09-26T00:00:00Z
P6179
1016922153